Cargando…

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond

Monoclonal antibodies are an effective and growing class of pharmaceuticals for the treatment and prevention of a broad range of non-communicable and infectious diseases; however, most low- and middle-income countries have limited access to these innovative products. Many factors contribute to the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gieber, Lisa, Muturi-Kioi, Vincent, Malhotra, Shelly, Sitlani, Ayesha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141866/ https://www.ncbi.nlm.nih.gov/pubmed/37115494 http://dx.doi.org/10.1007/s40290-023-00473-z

Ejemplares similares

Specialization in acute care surgery in low-income and middle-income countries
por: Yi, Sojung, et al.
Publicado: (2017)

Payment Arrangements for Private Healthcare Purchasing Under Publicly Funded Systems in Low- and Middle-Income Countries: Issues and Implications
por: Honda, Ayako, et al.
Publicado: (2020)

Enhancing Mental Health Research Publication from Low and Middle-Income Countries
por: Saxena, Shekhar, et al.
Publicado: (2004)

Incentivizing an exodus: The implications of recruiting nurses from low-middle income countries to high-income countries
por: Bortolussi-Courval, Émilie, et al.
Publicado: (2023)

Next-generation community genetics for low- and middle-income countries
por: Kingsmore, Stephen F, et al.
Publicado: (2012)

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
por: Reichert, Janice M.
Publicado: (2012)

UK Biobank: opportunities for cardiovascular research
por: Littlejohns, Thomas J, et al.
Publicado: (2019)

A Window of Opportunity for Newborn Screening
por: Bailey Jr, Donald B.
Publicado: (2022)

Health information priorities for more effective implementation and monitoring of non-communicable disease programs in low- and middle-income countries: lessons from the Pacific
por: Gouda, Hebe N., et al.
Publicado: (2015)

Reliable direct measurement of causes of death in low- and middle-income countries
por: Jha, Prabhat
Publicado: (2014)

Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017)

Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017)

Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
por: Cummings, Jeffrey
Publicado: (2023)

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
por: Baum, Charles, et al.
Publicado: (2015)

Clinical Exome Reanalysis: Current Practice and Beyond
por: Ji, Jianling, et al.
Publicado: (2021)

Network Physiology of Exercise: Beyond Molecular and Omics Perspectives
por: Balagué, Natàlia, et al.
Publicado: (2022)

Inevitable future: space colonization beyond Earth with microbes first
por: Lopez, Jose V, et al.
Publicado: (2019)

Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
por: Brazier, John, et al.
Publicado: (2015)

Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
por: Jacobson, Sheldon H., et al.
Publicado: (2021)

Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition
por: O’Connell, Isabel, et al.
Publicado: (2023)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

Power of mentorship for civilian and military acute care surgeons: identifying and leveraging opportunities for longitudinal professional development
por: Knowlton, Lisa Marie, et al.
Publicado: (2023)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

What are the threats from antimicrobial resistance for maternity units in low- and middle- income countries?
por: Graham, Wendy J., et al.
Publicado: (2016)

Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond
por: Furtner, Daniel, et al.
Publicado: (2021)

Towards a more efficient healthcare system: Opportunities and challenges caused by hospital closures amid the COVID-19 pandemic
por: Saghafian, Soroush, et al.
Publicado: (2022)

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
por: Ananworanich, Jintanat, et al.
Publicado: (2021)

Menstrual hygiene management among adolescent schoolgirls in low- and middle-income countries: research priorities
por: Phillips-Howard, Penelope A., et al.
Publicado: (2016)

Need for Improvements in Medical Device Management in Low- and Middle-Income Countries: Applying Learnings from Japan’s Experience
por: Inagaki, Daisuke, et al.
Publicado: (2023)

Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making
por: Schlegl, Evelyn, et al.
Publicado: (2017)

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
por: Farghaly, Mohamed Nasr Mahmoud Hassan, et al.
Publicado: (2022)

Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries
por: Garrett, Nigel J., et al.
Publicado: (2018)

Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry
por: Padula, William V., et al.
Publicado: (2018)

Long-term oral anticoagulation for atrial fibrillation in low and middle income countries
por: Ramakumar, Venkatakrishnan, et al.
Publicado: (2021)

Protecting the confidentiality and security of personal health information in low- and middle-income countries in the era of SDGs and Big Data
por: Beck, Eduard J., et al.
Publicado: (2016)

Disability-inclusive responses to COVID-19: Lessons learnt from research on social protection in low- and middle-income countries
por: Banks, Lena Morgon, et al.
Publicado: (2021)

The need to incorporate the impact of population ageing into the post-COVID-19 policy and planning reset in Low and Middle Income Countries
por: Solanki, Geetesh, et al.
Publicado: (2021)

Practical Notes on the Current ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer in Resource-Constrained Environments of Low- to Middle-Income Countries
por: Maurel, Jean-Marc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_krboe8lsl98e1v9ghempn0r8h9